DE69230790T2 - Arzneimittel zur Behandlung von durch Babesia verursachten Protozoeninfektionen - Google Patents

Arzneimittel zur Behandlung von durch Babesia verursachten Protozoeninfektionen

Info

Publication number
DE69230790T2
DE69230790T2 DE69230790T DE69230790T DE69230790T2 DE 69230790 T2 DE69230790 T2 DE 69230790T2 DE 69230790 T DE69230790 T DE 69230790T DE 69230790 T DE69230790 T DE 69230790T DE 69230790 T2 DE69230790 T2 DE 69230790T2
Authority
DE
Germany
Prior art keywords
pct
infections caused
babesia
protozoal infections
medicines used
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69230790T
Other languages
English (en)
Other versions
DE69230790D1 (de
Inventor
Winston Edward Gutteridge
Alan Thomas Hudson
Victoria Susan Latter
Mary Pudney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of DE69230790D1 publication Critical patent/DE69230790D1/de
Publication of DE69230790T2 publication Critical patent/DE69230790T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE69230790T 1991-12-18 1992-12-17 Arzneimittel zur Behandlung von durch Babesia verursachten Protozoeninfektionen Expired - Lifetime DE69230790T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919126874A GB9126874D0 (en) 1991-12-18 1991-12-18 Medicaments
PCT/GB1992/002344 WO1993011756A1 (en) 1991-12-18 1992-12-17 Medicament for treatment of protozoal infections

Publications (2)

Publication Number Publication Date
DE69230790D1 DE69230790D1 (de) 2000-04-20
DE69230790T2 true DE69230790T2 (de) 2000-08-17

Family

ID=10706474

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230790T Expired - Lifetime DE69230790T2 (de) 1991-12-18 1992-12-17 Arzneimittel zur Behandlung von durch Babesia verursachten Protozoeninfektionen

Country Status (7)

Country Link
US (1) US5561164A (de)
EP (1) EP0572615B1 (de)
AT (1) ATE190484T1 (de)
DE (1) DE69230790T2 (de)
ES (1) ES2144452T3 (de)
GB (1) GB9126874D0 (de)
WO (1) WO1993011756A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009981A1 (en) * 1997-08-21 1999-03-04 P.N. Gerolymatos S.A. Use of phanquinone for the treatment of alzheimer's disease
US6114382A (en) * 1998-11-11 2000-09-05 Moretti; Itagiba G. Methods for treating inflammatory bowel disease
WO2009007991A2 (en) 2007-04-19 2009-01-15 Ipca Laboratories Limited A new process for preparation of atovaquone and novel intermediates thereof
EP2093207A1 (de) * 2008-02-06 2009-08-26 Julius-Maximilians-Universität Würzburg Aus tropischen Lianen isolierte antiinfektiöse und antitumorale Verbindungen
EP2250145A4 (de) * 2008-03-07 2012-02-22 Alkem Lab Ltd Herstellung von naphthochinon-verbindungen mithilfe von 2,3-dihalonapthochinon
CN101781196B (zh) * 2009-01-20 2013-11-27 武汉泰祥通生物技术有限公司 一种制备4-(4-氯苯基)-环己基-1-甲酸的方法
WO2013074930A1 (en) * 2011-11-18 2013-05-23 Howard University Methods for treating leishmaniasis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175319A (en) * 1983-04-14 1992-12-29 Burroughs Wellcome Co. Naphthoquinone derivatives
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
US5053432A (en) * 1983-04-14 1991-10-01 Burroughs Wellcome Co. Naphthoquinone derivatives
HU208624B (en) * 1988-08-16 1993-12-28 Wellcome Found Process for producing pharmaceutical compositions containing naphtoquinone derivatives effective against pneumocystis infections
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
US5225184A (en) * 1988-08-16 1993-07-06 Burroughs Wellcome Co. Medicaments
GB8921516D0 (en) * 1989-09-22 1989-11-08 Wellcome Found Medicaments
GB8923254D0 (en) * 1989-10-16 1989-12-06 Wellcome Found Medicaments

Also Published As

Publication number Publication date
EP0572615B1 (de) 2000-03-15
WO1993011756A1 (en) 1993-06-24
ATE190484T1 (de) 2000-04-15
ES2144452T3 (es) 2000-06-16
GB9126874D0 (en) 1992-02-19
EP0572615A1 (de) 1993-12-08
DE69230790D1 (de) 2000-04-20
US5561164A (en) 1996-10-01

Similar Documents

Publication Publication Date Title
DE59407237D1 (de) Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ES2144151T3 (es) Benzotiazepinas hipolipidemicas.
DE69230790D1 (de) Arzneimittel zur Behandlung von durch Babesia verursachten Protozoeninfektionen
ATE143947T1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
DE69312297T2 (de) Verwendung von 2-[4-(-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphtoquinon zur behandlung von krebs
DE68916651D1 (de) Heilmittel zur behandlung von toxoplasmose.
ATE194076T1 (de) Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE143946T1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
ATE107504T1 (de) Arzneimittel zur behandlung von kryptosporidiose.
ATE232867T1 (de) Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen
ATE357256T1 (de) Arzneimittel zur behandlung von störungen des zirkadianen rhythmus
GEP19970834B (en) 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone